These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 25615907

  • 1. Tubulin-binding agents down-regulate matrix metalloproteinase-2 and -9 in human hormone-refractory prostate cancer cells – a critical role of Cdk1 in mitotic entry.
    Chang WL, Yu CC, Chen CS, Guh JH.
    Biochem Pharmacol; 2015 Mar 01; 94(1):12-21. PubMed ID: 25615907
    [Abstract] [Full Text] [Related]

  • 2. MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.
    Pai HC, Kumar S, Shen CC, Liou JP, Pan SL, Teng CM.
    PLoS One; 2015 Mar 01; 10(4):e0123819. PubMed ID: 25874627
    [Abstract] [Full Text] [Related]

  • 3. FRET-Based Sorting of Live Cells Reveals Shifted Balance between PLK1 and CDK1 Activities During Checkpoint Recovery.
    Lafranchi L, Müllers E, Rutishauser D, Lindqvist A.
    Cells; 2020 Sep 19; 9(9):. PubMed ID: 32961751
    [Abstract] [Full Text] [Related]

  • 4. CDK1 switches mitotic arrest to apoptosis by phosphorylating Bcl-2/Bax family proteins during treatment with microtubule interfering agents.
    Zhou L, Cai X, Han X, Xu N, Chang DC.
    Cell Biol Int; 2014 Jun 19; 38(6):737-46. PubMed ID: 24677263
    [Abstract] [Full Text] [Related]

  • 5. The newly synthesized 2-arylnaphthyridin-4-one, CSC-3436, induces apoptosis of non-small cell lung cancer cells by inhibiting tubulin dynamics and activating CDK1.
    Chang LC, Yu YL, Liu CY, Cheng YY, Chou RH, Hsieh MT, Lin HY, Hung HY, Huang LJ, Wu YC, Kuo SC.
    Cancer Chemother Pharmacol; 2015 Jun 19; 75(6):1303-15. PubMed ID: 25947085
    [Abstract] [Full Text] [Related]

  • 6. Sequential Cdk1 and Plk1 phosphorylation of protein tyrosine phosphatase 1B promotes mitotic cell death.
    O'Donovan DS, MacFhearraigh S, Whitfield J, Swigart LB, Evan GI, Mc Gee MM.
    Cell Death Dis; 2013 Jan 24; 4(1):e468. PubMed ID: 23348582
    [Abstract] [Full Text] [Related]

  • 7. A novel quinazoline-based analog induces G2/M cell cycle arrest and apoptosis in human A549 lung cancer cells via a ROS-dependent mechanism.
    Shi H, Li Y, Ren X, Zhang Y, Yang Z, Qi C.
    Biochem Biophys Res Commun; 2017 Apr 29; 486(2):314-320. PubMed ID: 28302490
    [Abstract] [Full Text] [Related]

  • 8. Piperine inhibits proliferation of human osteosarcoma cells via G2/M phase arrest and metastasis by suppressing MMP-2/-9 expression.
    Zhang J, Zhu X, Li H, Li B, Sun L, Xie T, Zhu T, Zhou H, Ye Z.
    Int Immunopharmacol; 2015 Jan 29; 24(1):50-8. PubMed ID: 25479727
    [Abstract] [Full Text] [Related]

  • 9. Phosphorylation of SAF-A/hnRNP-U Serine 59 by Polo-Like Kinase 1 Is Required for Mitosis.
    Douglas P, Ye R, Morrice N, Britton S, Trinkle-Mulcahy L, Lees-Miller SP.
    Mol Cell Biol; 2015 Aug 29; 35(15):2699-713. PubMed ID: 25986610
    [Abstract] [Full Text] [Related]

  • 10. FGF inhibits the activity of the cyclin B1/CDK1 kinase to induce a transient G₂arrest in RCS chondrocytes.
    Tran T, Kolupaeva V, Basilico C.
    Cell Cycle; 2010 Nov 01; 9(21):4379-86. PubMed ID: 21051949
    [Abstract] [Full Text] [Related]

  • 11. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G, Besnard E, Fisher D, Piette J, Dulić V.
    Oncogene; 2011 Oct 13; 30(41):4261-74. PubMed ID: 21532626
    [Abstract] [Full Text] [Related]

  • 12. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways.
    Chen YC, Lu PH, Pan SL, Teng CM, Kuo SC, Lin TP, Ho YF, Huang YC, Guh JH.
    Biochem Pharmacol; 2007 Jun 30; 74(1):10-9. PubMed ID: 17475221
    [Abstract] [Full Text] [Related]

  • 13. Stathmin and microtubules regulate mitotic entry in HeLa cells by controlling activation of both Aurora kinase A and Plk1.
    Silva VC, Cassimeris L.
    Mol Biol Cell; 2013 Dec 30; 24(24):3819-31. PubMed ID: 24152729
    [Abstract] [Full Text] [Related]

  • 14. Role of cyclin B1/Cdc2 in mediating Bcl-XL phosphorylation and apoptotic cell death following nocodazole-induced mitotic arrest.
    Choi HJ, Zhu BT.
    Mol Carcinog; 2014 Feb 30; 53(2):125-37. PubMed ID: 22949227
    [Abstract] [Full Text] [Related]

  • 15. Preferential Killing of Tetraploid Colon Cancer Cells by Targeting the Mitotic Kinase PLK1.
    Jemaà M, Kifagi C, Serrano SS, Massoumi R.
    Cell Physiol Biochem; 2020 Apr 08; 54(2):303-320. PubMed ID: 32259417
    [Abstract] [Full Text] [Related]

  • 16. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
    Chung KS, Choi HE, Shin JS, Cho YW, Choi JH, Cho WJ, Lee KT.
    Carcinogenesis; 2013 Aug 08; 34(8):1852-60. PubMed ID: 23615402
    [Abstract] [Full Text] [Related]

  • 17. MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cells.
    Yang JS, Hour MJ, Huang WW, Lin KL, Kuo SC, Chung JG.
    J Pharmacol Exp Ther; 2010 Aug 08; 334(2):477-88. PubMed ID: 20463006
    [Abstract] [Full Text] [Related]

  • 18. Blocking Mitotic Exit of Ovarian Cancer Cells by Pharmaceutical Inhibition of the Anaphase-Promoting Complex Reduces Chromosomal Instability.
    Raab M, Sanhaji M, Zhou S, Rödel F, El-Balat A, Becker S, Strebhardt K.
    Neoplasia; 2019 Apr 08; 21(4):363-375. PubMed ID: 30851646
    [Abstract] [Full Text] [Related]

  • 19. Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via insulin-like growth factor-1 receptor-independent mechanism.
    Waraky A, Akopyan K, Parrow V, Strömberg T, Axelson M, Abrahmsén L, Lindqvist A, Larsson O, Aleem E.
    Oncotarget; 2014 Sep 30; 5(18):8379-92. PubMed ID: 25268741
    [Abstract] [Full Text] [Related]

  • 20. Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.
    Matsuhashi A, Ohno T, Kimura M, Hara A, Saio M, Nagano A, Kawai G, Saitou M, Takigami I, Yamada K, Okano Y, Shimizu K.
    Curr Cancer Drug Targets; 2012 Jul 30; 12(6):625-39. PubMed ID: 22463590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.